Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
作者： Michael D. Brooks , Monika L. Burness , Max S. Wicha
DOI: 10.1016/J.STEM.2015.08.014
关键词:
摘要: Cellular heterogeneity represents one of the greatest challenges in cancer therapeutics. In many malignancies, this heterogeneity is generated during tumor evolution through a …
core.ac.uk
elsevier.com
sci-hub.se 参考文章(125)
Katherine E Sleeman, Howard Kendrick, Alan Ashworth, Clare M Isacke, Matthew J Smalley, CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells Breast Cancer Research. ,vol. 8, pp. 1- 6 ,(2005) , 10.1186/BCR1371
Qin Pan, Qiao Li, Shuang Liu, Ning Ning, Xiaolian Zhang, Yingxin Xu, Alfred E. Chang, Max S. Wicha, Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches Stem Cells. ,vol. 33, pp. 2085- 2092 ,(2015) , 10.1002/STEM.2039
Bhupinder Pal, Yunshun Chen, Andrew Bert, Yifang Hu, Julie M. Sheridan, Tamara Beck, Wei Shi, Keith Satterley, Paul Jamieson, Gregory J. Goodall, Geoffrey J. Lindeman, Gordon K. Smyth, Jane E. Visvader, Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits Breast Cancer Research. ,vol. 17, pp. 85- 85 ,(2015) , 10.1186/S13058-015-0585-0
Shany Koren, Linsey Reavie, Joana Pinto Couto, Duvini De Silva, Michael B. Stadler, Tim Roloff, Adrian Britschgi, Tobias Eichlisberger, Hubertus Kohler, Olulanu Aina, Robert D. Cardiff, Mohamed Bentires-Alj, PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours. Nature. ,vol. 525, pp. 114- 118 ,(2015) , 10.1038/NATURE14669
Alexandra Van Keymeulen, May Yin Lee, Marielle Ousset, Sylvain Brohée, Sandrine Rorive, Rajshekhar R. Giraddi, Aline Wuidart, Gaëlle Bouvencourt, Christine Dubois, Isabelle Salmon, Christos Sotiriou, Wayne A. Phillips, Cédric Blanpain, Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity Nature. ,vol. 525, pp. 119- 123 ,(2015) , 10.1038/NATURE14665
A. Fabi, G. Metro, A. Di Benedetto, C. Nisticò, P. Vici, E. Melucci, B. Antoniani, L. Perracchio, I. Sperduti, M. Milella, F. Cognetti, M. Mottolese, Clinical Significance of PTEN and p-Akt Co-Expression in HER2-Positive Metastatic Breast Cancer Patients Treated with Trastuzumab-Based Therapies Oncology. ,vol. 78, pp. 141- 149 ,(2010) , 10.1159/000312656
Sarah J. Conley, Trenton L. Baker, Joseph P. Burnett, Rebecca L. Theisen, Douglas Lazarus, Christian G. Peters, Shawn G. Clouthier, Scott Eliasof, Max S. Wicha, CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancer Breast Cancer Research and Treatment. ,vol. 150, pp. 559- 567 ,(2015) , 10.1007/S10549-015-3349-8
D. Friedmann-Morvinski, E. A. Bushong, E. Ke, Y. Soda, T. Marumoto, O. Singer, M. H. Ellisman, I. M. Verma, Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science. ,vol. 338, pp. 1080- 1084 ,(2012) , 10.1126/SCIENCE.1226929
P N Munster, K T Thurn, S Thomas, P Raha, M Lacevic, A Miller, M Melisko, R Ismail-Khan, H Rugo, M Moasser, S E Minton, A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer British Journal of Cancer. ,vol. 104, pp. 1828- 1835 ,(2011) , 10.1038/BJC.2011.156
H Korkaya, A Paulson, F Iovino, M S Wicha, HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene. ,vol. 27, pp. 6120- 6130 ,(2008) , 10.1038/ONC.2008.207